Theodore Polizos
Foot & Ankle Surgery · Chicago, ILNPI 1811080138
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $29,561 of the $47,079 with a category attached, or 62.8%. Smith+Nephew accounts for 94.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $25,317 and has fallen 91.6% since, to $2,130 in 2025. Among foot & ankle surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $202.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$44K
- Organogenesis Inc.$1K
- Next Science LLC$853
- Osiris Therapeutics Inc.$217
- Integra Lifesciences Corporation$116
- Tenex Health Inc.$51
- plus $234 from 9 others
What the payments were for
- Consulting fees$1,0802%
- Speaking & faculty fees$29,56163%
- Travel & lodging$9,56020%
- Food & beverage$6,87915%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 164 | $44,498 |
| Organogenesis Inc. | 37 | $1,111 |
| Next Science LLC | 17 | $853 |
| Osiris Therapeutics Inc. | 2 | $217 |
| Integra Lifesciences Corporation | 1 | $116 |
| Tenex Health Inc. | 1 | $51 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| Davol Inc. | 1 | $38 |
| Stryker | 1 | $35 |
| Bioventus LLC | 1 | $30 |
| Kerecis Limited | 1 | $27 |
| ETS Wound Care LLC | 1 | $20 |
| Aroa Biosurgery Incorporated | 1 | $19 |
| Treace Medical Concepts, Inc. | 1 | $19 |
| Reprise Biomedical, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$47,079 in reported general payments places this provider in the 95th percentile of 555 foot & ankle surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 12 | $16,651 |
| CiclopiroxCiclopirox Olamine | 31 | $1,055 |
| Minocycline Hcl | 53 | $841 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $528 |
| Cefadroxil | 21 | $229 |
| Ciprofloxacin Hcl | 14 | $134 |
| Doxycycline Hyclate | 26 | $116 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $103 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $44,498 | $16,65112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 555 foot & ankle surgery providers in Illinois.
Other foot & ankle surgery in Chicago
- Edgardo Rodriguez CollazoChicago$755K
- Stephanie OexemanChicago$206K
- Jeffrey AlexanderChicago$158K
- Matthew GaroufalisChicago$151K
- George HolmesChicago$134K
- Milap PatelChicago$52K
- Simon LeeChicago$34K
- Wonyong LeeChicago$23K
- Kamran HamidChicago$19K
- Souleymane DialloChicago$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.